Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes

Nick S R Lan, Regina S Y Hong, Christopher Ryan, Alicia J Jenkins, P Gerry Fegan

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.

Original languageEnglish
Pages (from-to)526-528
Number of pages3
JournalPrimary care diabetes
Issue number5
Publication statusPublished - Oct 2023

Cite this